New York - Session 2025-2026
Title: Relates to the availability of opioid reversal agents
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.
Tracking state legislation? Support LegiList with a small contribution. Independent, ad-free, and built by one developer.
| Date | Event | Detail |
|---|---|---|
| 2024-12-31 | Introduced | Bill introduced |
| 2026-01-12 | Status | in_committee |
| 2026-01-12 | Latest Action | In Senate Committee |
| Bill | Title | Status |
|---|---|---|
| A 8820 | Authorizes the office of cannabis management and cannabis control board establish a track and trace program | in_committee |
| A 10060 | Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as part of required health education courses | in_committee |
| A 10810 | Prohibits adult-use cannabis dispensaries from being located within a certain distance of the property boundary of a public school, public park, or beach | in_committee |
| A 9002 | Relates to exemptions from the recipient restriction program | in_committee |
| S 7984 | Relates to exemptions from the recipient restriction program | in_committee |
| S 8951 | Prohibits cannabis inversion | in_committee |
| S 9627 | Authorizes certain patients to use medical cannabis at certain health care facilities | in_committee |
| S 56 | Establishes a drug checking program | in_committee |